EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 -2.010
March 31, 2026 -0.8163
December 31, 2025 -0.7256
September 30, 2025 -0.7524
June 30, 2025 -0.6802
March 31, 2025 -0.2814
December 31, 2024 -7.780
September 30, 2024 -0.5856
June 30, 2024 -3.856
March 31, 2024 1.137
December 31, 2023 -2.676
September 30, 2023 -9.208
June 30, 2023 -37.73
March 31, 2023 -36.46
December 31, 2022 -80.08
September 30, 2022 364.59
June 30, 2022 -1069.40
March 31, 2022 -1.654M
December 31, 2021 -3191.50
September 30, 2021 -13720.22
June 30, 2021 -6843.48
March 31, 2021 -22750.56
December 31, 2020 -26281.92
Date Value
September 30, 2020 -19836.18
June 30, 2020 -7039.62
March 31, 2020 -8201.76
December 31, 2019 -2008.44
September 30, 2019 -7053.90
June 30, 2019 -10341.66
March 31, 2019 -11046.84
December 31, 2018 -9535.68
September 30, 2018 -6394.92
June 30, 2018 -9083.76
March 31, 2018 -12258.54
December 31, 2017 -8820.00
September 30, 2017 -11760.00
June 30, 2017 -11340.00
March 31, 2017 -12180.00
December 31, 2016 -26880.00
September 30, 2016 -13741.56
June 30, 2016 -16201.08
March 31, 2016 -8555.82
December 31, 2015 -2862.30
September 30, 2015 -8051.40
June 30, 2015 -9447.48
March 31, 2015 -5118.54

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 0.305
Alnylam Pharmaceuticals, Inc. 15.72
Anika Therapeutics, Inc. 0.2412
Savara, Inc. -0.1587
Vericel Corp. 0.0422